1. COVID-19 vaccines: modes of immune activation and future challenges;Teijaro;Nature Review Immunology,2021
2. Adjuvanting a subunit COVID-19 vaccine to induce protective immunity;Arunachalam;Nature,2021
3. N. Andrews, J. Stowe, F. Kirsebom, S. Toffa, T. Rickeard, E. Gallagher, C. Gower, M. Kall, N. Groves, A.M. O'Connell, D. Simons, P.B. Blomquist, A. Zaidi, S. Nash, N. Iwani Binti Abdul Aziz, S. Thelwall, G. Dabrera, R. Myers, G. Amirthalingam, S. Gharbia, J.C. Barrett, R. Elson, S.N. Ladhani, N. Ferguson, M. Zambon, C.N.J. Campbell, K. Brown, S. Hopkins, M. Chand, M. Ramsay, J. Lopez Bernal, Covid-19 vaccine effectiveness against the Omicron (B. 1.1. 529) variant, New England Journal of Medicine, 386 (2022) 1532-1546.
4. Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study, Effectiveness of mRNA-1273 against delta, mu, and other emerging variants of SARS-CoV-2: test negative case-control study;Bruxvoort;BMJ,2021
5. Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2;Ebinger;Nature Medicine,2021